Featured

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...

A LONDON-based fintech start-up profiled in BV’s feature on the recent Gibfin conference, Lendo, is making headlines for its pioneering approach towards regulated cryptocurrency. Forbes...

As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...

Debts, faulty trigger mechanisms and a link to the Sandy Hook massacre have all harmed the US gun manufacturer in recent months REMINGTON Outdoor Company,...

MIT, with its reputation for academic rigor and innovation, attracts graduate students from around the world. It can be worthwhile, it can be fun,...

MIT, with its reputation for academic rigor and innovation, attracts graduate students from around the world. It can be worthwhile, it can be fun,...

A fundamental shift is needed to avert devastating consequences, says high-level panel on water A HIGH-level Panel on Water consisting of 11 Heads of State...

Cryogenics takes a giant step sideways with glassy grey matter and voluntary, um, suicide By HAL WILLIAMS NOW here’s a variation on control+alt+delete: get dead and...

Major banks are unwittingly laundering drug money to fund international arms deals, a former US Senate candidate tells BV editor HAL WILLIAMS US BUSINESS intelligence...

McDonald’s and Coca-Cola usher in new ideas to pep-up, perk-up and slim-down the customers in the queue By HAL WILLIAMS JUNK food has come a long...